CN Patent

CN114096267B — 特利加压素制剂

Assigned to Biovie Inc · Expires 2025-03-18 · 1y expired

What this patent protects

本公开提供了包含具有增加的浓度和长期储存稳定性的特利加压素的药物组合物。

USPTO Abstract

本公开提供了包含具有增加的浓度和长期储存稳定性的特利加压素的药物组合物。

Drugs covered by this patent

Patent Metadata

Patent number
CN114096267B
Jurisdiction
CN
Classification
—
Expires
2025-03-18
Drug substance claim
No
Drug product claim
No
Assignee
Biovie Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.